Intco Medical Technology Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Intco Medical Technology Co., Ltd. carries a market capitalization of 29.86B, placing it among publicly traded companies globally. Its enterprise value stands at 10.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 29.86B |
| Enterprise Value | 10.56B |
Share Statistics
Intco Medical Technology Co., Ltd. currently has 646.30M shares outstanding.
| Shares Outstanding | 646.30M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Intco Medical Technology Co., Ltd. trades at a trailing price-to-earnings ratio of 9.56. The price-to-sales ratio is 1.53, and the price-to-book ratio stands at 0.90.
| PE Ratio | 9.56 |
| PS Ratio | 1.53 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.86 |
| P/FCF Ratio | 5.83 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Intco Medical Technology Co., Ltd. trades at an EV/EBITDA multiple of 8.88 and an EV/FCF ratio of 3.58. The EV/Sales ratio of 1.06 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.88 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.06 |
| EV / EBITDA | 8.88 |
| EV / EBIT | 8.88 |
| EV / FCF | 3.58 |
Financial Position
Intco Medical Technology Co., Ltd. maintains a current ratio of 1.37, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 96.52, indicating elevated leverage, while an interest coverage ratio of 3.23 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.37 |
| Quick Ratio | 1.20 |
| Debt / Equity | 96.52 |
| Debt / EBITDA | 14.86 |
| Interest Coverage | 3.23 |
Financial Efficiency
Intco Medical Technology Co., Ltd. posts a return on equity of 9.87 and a return on invested capital of 3.45.
| Return on Equity (ROE) | 9.87 |
| Return on Assets (ROA) | 4.49 |
| Return on Invested Capital (ROIC) | 3.45 |
| Return on Capital Employed (ROCE) | 6.17 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.76 |
Taxes
Over the trailing twelve months, Intco Medical Technology Co., Ltd. has paid 131.41M in income taxes, reflecting an effective tax rate of 7.48.
| Income Tax | 131.41M |
| Effective Tax Rate | 7.48 |
Stock Price Statistics
Intco Medical Technology Co., Ltd.'s stock has gained approximately 79.14375% over the past 52 weeks. The 50-day moving average sits at 47.22, while the 200-day moving average is 45.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | 79.14375% |
| 50-Day Moving Average | 47.22 |
| 200-Day Moving Average | 45.08 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Intco Medical Technology Co., Ltd. generated 9.92B in revenue and converted that into 1.59B in net income, yielding earnings per share of 2.54. EBITDA reached 1.19B, while operating income came in at 1.19B.
| Revenue | 9.92B |
| Gross Profit | 2.45B |
| Operating Income | 1.19B |
| Pretax Income | 1.76B |
| Net Income | 1.59B |
| EBITDA | 1.19B |
| EBIT | 1.19B |
| Earnings Per Share (EPS) | 2.54 |
Balance Sheet
Intco Medical Technology Co., Ltd. holds 22.60B in cash and equivalents against 17.67B in total debt, resulting in a net debt position of 5.37B. Total book value stands at 16.83B, with working capital of 7.03B providing operational flexibility.
| Cash & Cash Equivalents | 22.60B |
| Total Debt | 17.67B |
| Net Debt | 5.37B |
| Equity (Book Value) | 16.83B |
| Book Value Per Share | 26.25 |
| Working Capital | 7.03B |
Cash Flow
After subtracting -2.61B in capital expenditures, free cash flow totaled -2.61B - equivalent to -4.06 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -2.61B |
| Free Cash Flow | -2.61B |
| FCF Per Share | -4.06 |
Margins
Intco Medical Technology Co., Ltd. operates with a gross margin of 24.72, reflecting its pricing power and cost economics. The operating margin of 11.98 and net profit margin of 16.01 provide insight into operational efficiency.
| Gross Margin | 24.72 |
| Operating Margin | 11.98 |
| Pretax Margin | 17.71 |
| Profit Margin | 16.01 |
| EBITDA Margin | 11.98 |
Dividends & Yields
The company's payout ratio of 22.62 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.59 |
| Dividend Yield | N/A |
| Payout Ratio | 22.62 |
| Shareholder Yield | -35.84 |
| FCF Yield | 17.16 |
Stock Splits
Intco Medical Technology Co., Ltd.'s most recent stock split took place on June 13, 2022 with a 5:6 split ratio.
| Last Split Date | 6/13/2022 |
| Split Ratio | 5:6 |
Scores
Intco Medical Technology Co., Ltd. posts an Altman Z-Score of 1.59, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.59 |